Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Center for Dialysis Innovation
AddedFeb 15, 2024
UpdatedJun 18, 2026
Center for Dialysis Innovation

Center for Dialysis Innovation

Series B

Center for Dialysis Innovation: Transforming dialysis care through bioengineering and biomaterial technologies since 2016.

HQ
Seattle, WA, US
Founded
2016
Overview
Compare
Fundraising
Employees

Center for Dialysis Innovation aims to transform dialysis care through biomaterial and bioengineering technologies. It envisions future dialysis therapy free of complications, fully restoring kidney health. The center focuses on reducing complications and enhancing patient well-being, independence, and self-care autonomy.

Since its founding in 2016, the Center for Dialysis Innovation has made significant strides in dialysis technology redesign. By leveraging advanced biomaterials and bioengineering, it has improved patient outcomes and set new standards in dialysis care.

Center for Dialysis Innovation - Similar Companies

Liberty Dialysis logo

Liberty Dialysis

DaVita logo

DaVita

davita.com

FMS Midwest Dialysis Centers logo

FMS Midwest Dialysis Centers

Fresenius Medical Care Cedar Hill logo

Fresenius Medical Care Cedar Hill

Implantable Artificial Kidney logo

Implantable Artificial Kidney

Fresenius Medical Care North America logo

Fresenius Medical Care North America

fmcna.com

Pure Life Renal logo

Pure Life Renal

plrenal.com

Nephrology Care Group logo

Nephrology Care Group

Fresenius Medical Care logo

Fresenius Medical Care

fresenius.com

Diality logo

Diality

diality.com

River 3 Renal logo

River 3 Renal

Usrc Roanoke logo

Usrc Roanoke

usrenalcare.com

US Kidney Research logo

US Kidney Research

Rejuvenate Kidney Transplant Solutions logo

Rejuvenate Kidney Transplant Solutions

Healionics logo

Healionics

healionics.com

Center for Dialysis Innovation - Quick Facts

Who are Center for Dialysis Innovation's competitors?

Companies similar to Center for Dialysis Innovation include Liberty Dialysis, DaVita, FMS Midwest Dialysis Centers and Fresenius Medical Care Cedar Hill.

When was Center for Dialysis Innovation founded?

Center for Dialysis Innovation was founded in 2016.

Where is Center for Dialysis Innovation's headquarters located?

Center for Dialysis Innovation's headquarters is located in Seattle, WA, US.

When was Center for Dialysis Innovation's last funding round?

Center for Dialysis Innovation's most recent funding round was for $15M (USD) in March 2017.

How much has Center for Dialysis Innovation raised to-date?

As of Mar 14, 2017, Center for Dialysis Innovation has raised a total of $15M (USD).

How many employees does Center for Dialysis Innovation have?

Center for Dialysis Innovation has 30 employees as of Feb 4, 2024.

Center for Dialysis Innovation - Classification

Technology
  • Bioengineering
  • Biomaterials
Customer
  • Non-Profit
Main Product
  • Dialysis Treatment
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 610000Educational Services
  • 611000Educational Services
SIC
  • 8200Educational Services
  • 8290Schools And Educational Services, Not Elsewhere Classified